News
Koru Pharma presents advanced solutions for rejuvenationKoru Pharma, a pioneer in anti-aging and rejuvenation, proudly introduces its newest products: Crystal Healer PN and Crystal Healer PN+.
Read more
Koru Pharma Recognised by CHOSUN DAILY Koru Pharma, a leading exporter of medical and beauty products, has been featured in Joseon Ilbo
Read more
Koru Pharma New HeadquartersKoru Pharma Co., Ltd. has expanded its headquarters office to the 16th floor of a newly built high-rise in Seoul’s bustling Gangnam district.
Read more
Koru Pharma Launches AVALON Clinical Trials in ChinaKoru Pharma is taking a significant step forward in solidifying its presence in Asia’s largest market by initiating clinical trials for our cross-linked hyaluronic acid filler, “AVALON ,” in China.
Read more
Breakthrough Patent for Next-Generation Filler TechnologyKoru Pharma has secured a patent for its next-generation filler technology, eliminating the need for chemical cross-linking agents. This milestone advances our commitment to safer, more effective aesthetic solutions.
Read more
Celebrating Innovation at the 2024 Koru Pharma Gala NightOn June 22nd 2024, Koru Pharma warmly welcomed our esteemed clients and partners to a magical evening of music, cocktails, and hors d’oeuvres at the Gala Night 2024, held at the luxurious penthouse bar in Bangkok, Thailand.
Read more
Koru Pharma’s H Bloom obtains CE certificationKoru Pharma’s trademark product H Bloom is now CE approved.
Read more
Koru Pharma presents Elitox® 200 Units - Purified Botulinum Toxin Type A.Elitox®, Purified Botulinum Toxin Type A, the highest degree of purification of the toxin molecule 99.8%, to correct deep and medium wrinkles.
Read more
Koru Pharma in the spotlight of Chosun IlboHighlighted by a leading Korean newspaper, Koru Pharma is redefining the beauty industry by exporting premium aesthetic products to over 100 countries. Discover the story behind our founder’s vision and commitment to innovation.
Read more
I Want The Beauty Industry To Associate "MADE IN KOREA" With Koru PharmaRoman Vernidub, the CEO of Koru Pharma, plans to expand the manufacturing capacity of the company’s factory to 3 million syringes by the end of 2025 and reach a revenue of 70 billion won.
Read more
Benzinga features Mesohemp as a Professional Cosmetic LineBenzinga recently published an article about our new cosmetic line; Mesohemp.
Read more
Mesoheal® Glow Series launchThe Mesoheal® Glow Series represents a significant advancement in skincare technology, leveraging the latest scientific research and cutting-edge ingredients to deliver exceptional results.
Read more
Koru Pharma CEO Roman Vernidub Shares Insights on Doing Business in East Asia in TNW FeatureRoman Vernidub, the CEO of Koru Pharma, was featured in a story by The Next Web (TNW). The article delves into the unique challenges and opportunities for startups and businesses entering the East Asian market. As a leader in the pharmaceutical and aesthetic medicine industries, Roman brought valuable insights and practical strategies to the conversation.
Read more
Koru Pharma open manufacturing facility in KoreaOur new HA filler facility is comprised of a 1,800 square meter assembly area, along with designated product storage areas and a loading dock. Production capacity is 3 million syringes per annum.
Read more
Koru Pharma Launches New Brand: MesohempKoru Pharma has recognised the growing demand for hemp-based products in the market, and in response, the company has developed a new product line – Mesohemp. This marks...
Read more
Introducing Mesoheal® Shape 10mlKoru Pharma has expanded its Mesoheal® Body HA line with the introduction of the Mesoheal® Shape 10ml
Read more
Koru Pharma presents Elitox - Purified Botulinum Toxin Type A.The newest addition to Koru Pharma’s line of products provides temporary correction of deep and medium wrinkles, associated with muscle activity and signs of aging. Unlike other botulinum toxin analogs.
Read more
Koru Pharma Enhances Mesoheal Body HA 50ml with Innovative AdaptorKoru Pharma is proud to announce an exciting improvement to its Mesoheal Body HA 50ml product. In response to valuable feedback from clients, we have introduced a simple yet innovative adaptor designed to make the extraction process smoother and more efficient.
Read more
Koru Pharma Opens New R&D Laboratory in Chucheon, South KoreaKoru Pharma is excited to announce the opening of our state-of-the-art R&D laboratory in Chucheon, South Korea, which is fully equipped to support our ongoing research and development efforts. This new facility marks a significant milestone in our commitment to innovation and the advancement of medical solutions.
Read more
Koru Pharma develop MCO® Tech.Koru Pharma's R&D Institute completed development of MCO® Tech. (Minimising Cross-linking agent by Optimising reaction Technology), a technology that is used when manufacturing our dermal fillers.
Read more
Koru Pharma at IMCAS Asia 2024Koru Pharma Shines at Asia’s Premier B2B Event for Dermatology, Plastic Surgery, and Aging Science in Bangkok
Read more
Expanding Global Reach with Latest Launches at IMCAS ASIA 2024Koru Pharma Expands Global Reach with Latest Launches at IMCAS ASIA 2024
Read more
Koru Pharma at IMCAS Americas 2024Koru Pharma recently participated in IMCAS Americas held in São Paulo, Brazil, where we showcased our innovative medical solutions to professionals worldwide.
Read more
Dubai Derma 2024 - H Bloom Workshop by Dr.Carlos MuñozKoru Pharma participated in the 23rd edition of Dubai Derma, providing attendees with a distinctive opportunity to broaden their understanding.
Read more
AMWC Monaco 2024 SymposiumsAt Koru Pharma, we specialize in innovative medical solutions for corrective and aesthetic applications, delivering lasting results. We work closely with healthcare professionals to understand their needs and those of their patients.
Read more
Koru Pharma at AMWC Monaco 2024Koru Pharma had a successful experience at the industry’s leading event, dedicated to advancing physician education and cultivating valuable new professional relationships.
Read more
Koru Pharma at CIBE Guangzhou 2024Koru Pharma recently participated in CIBE Guangzhou 2024, which stands as China’s leading beauty industry platform. This prestigious aesthetic event provided us with the opportunity to engage with both our established partners and new industry experts.
Read more
Koru Pharma at Dubai Derma 2024Our first appearance at the Beauty Expo in Sydney, Australia, was a fantastic opportunity to introduce our innovative product range...
Read more
Koru Pharma Honored with President's Award for Outstanding Contribution to Export ExcellenceIn recognition of excellence in international trade, Koru Pharma has been bestowed with the prestigious President’s Award for achieving an outstanding export milestone of 10 million USD.
Read more
Koru Pharma’s AVALON™ Fillers obtain Certification in the Russian FederationKoru Pharma’s premium hyaluronic acid fillers AVALON™ have recently been granted product approval by the Federal Service for Surveillance in Healthcare of Russian Federation.
Read more
